MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

MediBeacon-FDA-GFR

More Like This

First Irish patient implanted with innovative heart failure management system from Irish Company FIRE1

PR Newswire associated0

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

PR Newswire associated0

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

PR Newswire associated0

LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

PR Newswire associated0

Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension

FIRE1 Completes Enrollment in U.S. Early Feasibility Study of Innovative Remote Heart Failure Monitoring System

PR Newswire associated0

Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure